Parkinson's disease

Label

• Parkinson's disease (literal)

Membro di

• Parole chiave di "Altered dopamine homeostasis differentially affects mitochondrial voltage-dependent anion channels turnover" (Insieme di parole chiave)
• Parole chiave di "Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists" (Insieme di parole chiave)
• Keywords of "Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study" (Insieme di parole chiave)
• Keywords of "PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family" (Insieme di parole chiave)
• Parole chiave di "Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease" (Insieme di parole chiave)
• Parole chiave di "Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson's disease." (Insieme di parole chiave)
• Parole chiave di "An XAS study of the sulfur environment in human neuromelanin and its synthetic analogs." (Insieme di parole chiave)
• Keywords of "Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration" (Insieme di parole chiave)
• Parole chiave di "Reduction of the Nitro Group to Amine by Hydroiodic Acid to Synthesize o-Aminophenol Derivatives as Putative Degradative Markers of Neuromelanin" (Insieme di parole chiave)
• Parole chiave di "Levodopa response in dementia with lewy bodies: A 1-year follow-up study" (Insieme di parole chiave)
• Parole chiave di "An exome study of Parkinson's disease in Sardinia, a Mediterranean genetic isolate" (Insieme di parole chiave)
• Parole chiave di "Influences of Dopaminergic Treatment on Motor Cortex in Parkinson Disease: A MRI/MRS Study" (Insieme di parole chiave)
• Parole chiave di "Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study" (Insieme di parole chiave)
• Parole chiave di "Adenosine A(2A) receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats" (Insieme di parole chiave)
• Keywords of "The Parkinson’s disease associated Gpr37 receptor has a role during mouse testis development" (Insieme di parole chiave)
• Parole chiave di "Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study." (Insieme di parole chiave)
• Keywords of "GPR37 associates with the dopamine transporter to modulate dopamine uptake" (Insieme di parole chiave)
• Parole chiave di "Dopamine agonists and delusional jealousy in Parkinson's disease: A cross-sectional prevalence study" (Insieme di parole chiave)
• Keywords of "A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias" (Insieme di parole chiave)
• Keywords of "Superiority of PLK-2 as alpha-synuclein phosphorylating agent relies on unique specificity determinants" (Insieme di parole chiave)
• Parole chiave di "Neuromelanin inhibits CXCL10 expression in human astroglial cells" (Insieme di parole chiave)
• Parole chiave di "Altered dopamine receptor-mediated signalling in GR37/PAEL-R knockout mice" (Insieme di parole chiave)
• Keywords of "A Critical Evaluation of Behavioral Rodent Models of Motor Impairment Used for Screening of Antiparkinsonian Activity: The Case of Adenosine A(2A) Receptor Antagonists" (Insieme di parole chiave)
• Parole chiave di "Non-motor behavioral impairments depend on age and gender in mice lacking the Parkinson's disease related GPR37/Pael receptor" (Insieme di parole chiave)
• Keywords of "L-DOPA disrupts adenosine A(2A)-cannabinoid CB1-dopamine D-2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies" (Insieme di parole chiave)
• Keywords of "Altered dopamine receptor-mediated signalling in GR37/PAEL-R knockout mice" (Insieme di parole chiave)
• Keywords of "Assessment of Symptomatic and Neuroprotective Efficacy of Mucuna Pruriens Seed Extract in Rodent Model of Parkinson's Disease" (Insieme di parole chiave)
• Keywords of "A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset." (Insieme di parole chiave)
• Keywords of "Blockade of A(2A) receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata" (Insieme di parole chiave)
• Parole chiave di "The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients" (Insieme di parole chiave)
• Parole chiave di "Deep brain stimulation of the pedunculopontine tegmentum and subthalamic nucleus Effects on gait in Parkinson's disease" (Insieme di parole chiave)
• Keywords of "Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease" (Insieme di parole chiave)
• Keywords of "Challenges associated with metal chelation therapy in Alzheimer's disease." (Insieme di parole chiave)
• Parole chiave di "A Small Synthetic Cripto Blocking Peptide Improves Neural Induction, Dopaminergic Differentiation and Functional Integration of Mouse Embryonic Stem Cells in a Rat Model of Parkinson's Disease" (Insieme di parole chiave)
• Parole chiave di "The 6-hydroxydopamine model of Parkinson's disease" (Insieme di parole chiave)
• Parole chiave di "Novel investigational adenosine A(2A) receptor antagonists for Parkinson's disease." (Insieme di parole chiave)
• Keywords of "Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement" (Insieme di parole chiave)
• Keywords of "Cortical volume and folding abnormalities in Parkinson's disease patients with pathological gambling." (Insieme di parole chiave)
• Parole chiave di "Non-motor behavioral phenotypes depend on age and gender in mice lacking the Parkinson’s disease related GPR37/Pael receptor" (Insieme di parole chiave)
• Keywords of "Dopamine transporter availability in motor subtypes of de novo drug-naive Parkinson's disease" (Insieme di parole chiave)
• Keywords of "Eight year-cumulative incidence of parkinsonism (PK) and Parkinson's disease (PD). The Italian Longitudinal Study on Aging (ILSA)" (Insieme di parole chiave)
• Keywords of "Small molecules interacting with alpha-synuclein: antiaggregating and cytoprotective properties" (Insieme di parole chiave)
• Keywords of "Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD." (Insieme di parole chiave)
• Keywords of "Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease a multicenter study." (Insieme di parole chiave)
• Keywords of "Structural insights on physiological functions and pathological effects of alpha-Synuclein" (Insieme di parole chiave)
• Parole chiave di "Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study." (Insieme di parole chiave)
• Parole chiave di "Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements." (Insieme di parole chiave)
• Parole chiave di "What predicts cognitive decline in de novo Parkinson's disease?" (Insieme di parole chiave)
• Keywords of "Alpha-synuclein pore forming activity upon membrane association" (Insieme di parole chiave)
• Keywords of "Stable expression and functional characterization of a human nicotinic acetylcholine receptor with alpha 6 beta 2 properties: discovery of selective antagonists" (Insieme di parole chiave)
• Parole chiave di "Effect of resveratrol on mitochondrial function: Implications in parkin-associated familiar Parkinson's disease" (Insieme di parole chiave)
• Keywords of "Neuromelanin of the human substantia Nigra: An update" (Insieme di parole chiave)
• Keywords of "Prevalence of parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON collaborative study" (Insieme di parole chiave)
• Keywords of "Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions" (Insieme di parole chiave)
• Parole chiave di "How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson's disease?" (Insieme di parole chiave)
• Parole chiave di "Statins in neurological disorders: An overview and update" (Insieme di parole chiave)
• Keywords of "Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment" (Insieme di parole chiave)
• Parole chiave di "New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists" (Insieme di parole chiave)
• Parole chiave di "Regional and cellular expression of the parkin gene in the rat cerebral cortex" (Insieme di parole chiave)
• Keywords of "Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta" (Insieme di parole chiave)
• Keywords of "FRAXE intermediate alleles are associated with Parkinson's disease." (Insieme di parole chiave)

Value

• Parkinson's disease (literal)

Incoming links:

Ha membro

• Keywords of "Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions" (Insieme di parole chiave)
• Parole chiave di "Non-motor behavioral impairments depend on age and gender in mice lacking the Parkinson's disease related GPR37/Pael receptor" (Insieme di parole chiave)
• Keywords of "Challenges associated with metal chelation therapy in Alzheimer's disease." (Insieme di parole chiave)
• Parole chiave di "A Small Synthetic Cripto Blocking Peptide Improves Neural Induction, Dopaminergic Differentiation and Functional Integration of Mouse Embryonic Stem Cells in a Rat Model of Parkinson's Disease" (Insieme di parole chiave)
• Keywords of "Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment" (Insieme di parole chiave)
• Keywords of "Dopamine transporter availability in motor subtypes of de novo drug-naive Parkinson's disease" (Insieme di parole chiave)
• Parole chiave di "Non-motor behavioral phenotypes depend on age and gender in mice lacking the Parkinson’s disease related GPR37/Pael receptor" (Insieme di parole chiave)
• Parole chiave di "Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study." (Insieme di parole chiave)
• Keywords of "Alpha-synuclein pore forming activity upon membrane association" (Insieme di parole chiave)
• Parole chiave di "Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study." (Insieme di parole chiave)
• Keywords of "FRAXE intermediate alleles are associated with Parkinson's disease." (Insieme di parole chiave)
• Parole chiave di "Influences of Dopaminergic Treatment on Motor Cortex in Parkinson Disease: A MRI/MRS Study" (Insieme di parole chiave)
• Keywords of "Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration" (Insieme di parole chiave)
• Keywords of "Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement" (Insieme di parole chiave)
• Parole chiave di "Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease" (Insieme di parole chiave)
• Keywords of "Superiority of PLK-2 as alpha-synuclein phosphorylating agent relies on unique specificity determinants" (Insieme di parole chiave)
• Keywords of "Stable expression and functional characterization of a human nicotinic acetylcholine receptor with alpha 6 beta 2 properties: discovery of selective antagonists" (Insieme di parole chiave)
• Keywords of "A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias" (Insieme di parole chiave)
• Parole chiave di "An exome study of Parkinson's disease in Sardinia, a Mediterranean genetic isolate" (Insieme di parole chiave)
• Parole chiave di "Deep brain stimulation of the pedunculopontine tegmentum and subthalamic nucleus Effects on gait in Parkinson's disease" (Insieme di parole chiave)
• Parole chiave di "Altered dopamine homeostasis differentially affects mitochondrial voltage-dependent anion channels turnover" (Insieme di parole chiave)
• Keywords of "Blockade of A(2A) receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata" (Insieme di parole chiave)
• Keywords of "Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease a multicenter study." (Insieme di parole chiave)
• Parole chiave di "Regional and cellular expression of the parkin gene in the rat cerebral cortex" (Insieme di parole chiave)
• Keywords of "Small molecules interacting with alpha-synuclein: antiaggregating and cytoprotective properties" (Insieme di parole chiave)
• Keywords of "Assessment of Symptomatic and Neuroprotective Efficacy of Mucuna Pruriens Seed Extract in Rodent Model of Parkinson's Disease" (Insieme di parole chiave)
• Parole chiave di "Statins in neurological disorders: An overview and update" (Insieme di parole chiave)
• Parole chiave di "Altered dopamine receptor-mediated signalling in GR37/PAEL-R knockout mice" (Insieme di parole chiave)
• Parole chiave di "The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients" (Insieme di parole chiave)
• Parole chiave di "Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements." (Insieme di parole chiave)
• Keywords of "Neuromelanin of the human substantia Nigra: An update" (Insieme di parole chiave)
• Keywords of "Cortical volume and folding abnormalities in Parkinson's disease patients with pathological gambling." (Insieme di parole chiave)
• Keywords of "Eight year-cumulative incidence of parkinsonism (PK) and Parkinson's disease (PD). The Italian Longitudinal Study on Aging (ILSA)" (Insieme di parole chiave)
• Keywords of "PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family" (Insieme di parole chiave)
• Keywords of "GPR37 associates with the dopamine transporter to modulate dopamine uptake" (Insieme di parole chiave)
• Keywords of "Structural insights on physiological functions and pathological effects of alpha-Synuclein" (Insieme di parole chiave)
• Parole chiave di "Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study" (Insieme di parole chiave)
• Parole chiave di "Levodopa response in dementia with lewy bodies: A 1-year follow-up study" (Insieme di parole chiave)
• Parole chiave di "Reduction of the Nitro Group to Amine by Hydroiodic Acid to Synthesize o-Aminophenol Derivatives as Putative Degradative Markers of Neuromelanin" (Insieme di parole chiave)
• Keywords of "L-DOPA disrupts adenosine A(2A)-cannabinoid CB1-dopamine D-2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies" (Insieme di parole chiave)
• Parole chiave di "The 6-hydroxydopamine model of Parkinson's disease" (Insieme di parole chiave)
• Keywords of "Altered dopamine receptor-mediated signalling in GR37/PAEL-R knockout mice" (Insieme di parole chiave)
• Parole chiave di "Dopamine agonists and delusional jealousy in Parkinson's disease: A cross-sectional prevalence study" (Insieme di parole chiave)
• Keywords of "Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study" (Insieme di parole chiave)
• Parole chiave di "Effect of resveratrol on mitochondrial function: Implications in parkin-associated familiar Parkinson's disease" (Insieme di parole chiave)
• Keywords of "A Critical Evaluation of Behavioral Rodent Models of Motor Impairment Used for Screening of Antiparkinsonian Activity: The Case of Adenosine A(2A) Receptor Antagonists" (Insieme di parole chiave)
• Keywords of "The Parkinson’s disease associated Gpr37 receptor has a role during mouse testis development" (Insieme di parole chiave)
• Keywords of "Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease" (Insieme di parole chiave)
• Parole chiave di "Adenosine A(2A) receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats" (Insieme di parole chiave)
• Keywords of "A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset." (Insieme di parole chiave)
• Keywords of "Prevalence of parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON collaborative study" (Insieme di parole chiave)
• Parole chiave di "How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson's disease?" (Insieme di parole chiave)
• Keywords of "Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta" (Insieme di parole chiave)
• Parole chiave di "An XAS study of the sulfur environment in human neuromelanin and its synthetic analogs." (Insieme di parole chiave)
• Parole chiave di "Neuromelanin inhibits CXCL10 expression in human astroglial cells" (Insieme di parole chiave)
• Parole chiave di "What predicts cognitive decline in de novo Parkinson's disease?" (Insieme di parole chiave)
• Parole chiave di "Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson's disease." (Insieme di parole chiave)
• Parole chiave di "Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists" (Insieme di parole chiave)
• Keywords of "Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD." (Insieme di parole chiave)
• Parole chiave di "New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists" (Insieme di parole chiave)
• Parole chiave di "Novel investigational adenosine A(2A) receptor antagonists for Parkinson's disease." (Insieme di parole chiave)